Inactive Instrument
Intellego Technologies AB Stock
Stocks
INT
SE0016075063
Biotechnology & Medical Research
| 1 day | +4.96% |
| Manager | Title | Age | Since |
|---|---|---|---|
Simon Marshall
CEO | Chief Executive Officer | - | - |
Henrik Resmark
DFI | Director of Finance/CFO | 57 | 2026-02-09 |
Laila Ostertag
CTO | Chief Tech/Sci/R&D Officer | - | 2021-08-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Carl Olsson
CHM | Chairman | 64 | 2026-02-22 |
| Director/Board Member | 63 | 2026-02-22 | |
Mats Geijer
BRD | Director/Board Member | 49 | 2026-02-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/16/25 | Buy | Chief Executive Officer | 3,000 | 0.0101% | ||
| 9/15/25 | Buy | Chief Executive Officer | 2,805 | 0.0095% | ||
| 9/9/25 | Buy | Chief Executive Officer | 363 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.96% | +13.54% | - | - | 167M | ||
| -2.49% | -3.76% | +50.31% | +62.10% | 63.66B | ||
| -0.63% | -2.91% | +6.20% | +89.22% | 58.56B | ||
| -2.37% | -2.22% | +22.87% | +82.31% | 54.19B | ||
| -2.19% | -6.15% | +11.92% | +108.08% | 44.66B | ||
| -1.89% | -7.28% | +13.22% | +19.74% | 40.51B | ||
| -0.93% | -0.47% | +19.73% | +43.75% | 36.27B | ||
| +1.11% | -6.44% | +130.68% | +641.83% | 34.89B | ||
| -0.80% | +0.61% | +77.26% | +56.26% | 32.26B | ||
| -2.17% | +16.65% | -29.21% | +474.05% | 31.01B | ||
| Average | -0.74% | -1.22% | +33.67% | +175.26% | 44B | |
| Weighted average by Cap. | -1.48% | -1.85% | +32.16% | +150.90% |
Employees
64
Calendar
















